SPA
TWST icon

Sherbrooke Park Advisers’s Twist Bioscience TWST Stock Holding History

Sherbrooke Park Advisers’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,609
Closed -$242K – 532
2025
Q3 		$242K Buy
+8,609
New +$261K 0.11% 327
2025
Q1 		– Sell
-5,131
Closed -$238K – 944
2024
Q4 		$238K Buy
+5,131
New +$232K 0.08% 508

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Sherbrooke Park Advisers's TWST Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 8,609 shares — an estimated $242K sold.

Sherbrooke Park Advisers first reported a position in TWST in Q4 2024 and held it in 2 quarters. The position peaked at $242K in Q3 2025. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 8,609 Twist Bioscience shares in Q4 2025, an estimated $242K.
  • Sherbrooke Park Advisers first reported a position in Twist Bioscience in Q4 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Twist Bioscience position peaked at $242K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.